about
Molecular analysis of thymopentin binding to HLA-DR moleculesA step-by-step overview of the dynamic process of epitope selection by major histocompatibility complex class II for presentation to helper T cellsPeptide binding to HLA-DP proteins at pH 5.0 and pH 7.0: a quantitative molecular docking studySelective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pHPeptide exchange in MHC molecules.Binding interactions between peptides and proteins of the class II major histocompatibility complex.Intracellular hemolysin-producing Listeria monocytogenes strains inhibit macrophage-mediated antigen processingStability of empty and peptide-loaded class II major histocompatibility complex molecules at neutral and endosomal pH: comparison to class I proteins.Expression of a class II major histocompatibility complex (MHC) heterodimer in a lipid-linked form with enhanced peptide/soluble MHC complex formation at low pH.Enhanced binding of peptide antigen to purified class II major histocompatibility glycoproteins at acidic pH.Reduction of disulfide bonds during antigen processing: evidence from a thiol-dependent insulin determinant.Biochemical evidence for the rapid assembly and disassembly of processed antigen-major histocompatibility complex class II complexes in acidic vesicles of B cellsLong-lived complexes between peptide and class II major histocompatibility complex are formed at low pH with no requirement for pH neutralizationSubtle conformational changes induced in major histocompatibility complex class II molecules by binding peptides.Antigen processing by epidermal Langerhans cells correlates with the level of biosynthesis of major histocompatibility complex class II molecules and expression of invariant chainDetection of functional class II-associated antigen: role of a low density endosomal compartment in antigen processingA structural transition in class II major histocompatibility complex proteins at mildly acidic pH.DM determines the cryptic and immunodominant fate of T cell epitopes.Enhancement of peptide antigen presentation by a second peptide.The cell biology of antigen processing.Effects of pH and polysaccharides on peptide binding to class II major histocompatibility complex molecules.Kinetics of antigenic peptide binding to the class II major histocompatibility molecule I-AdA first-order reaction controls the binding of antigenic peptides to major histocompatibility complex class II molecules.Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.Endocytic recycling is required for the presentation of an exogenous peptide via MHC class II molecules.N-terminal elongation of a peptide determinant beyond the first primary anchor improves binding to H-2 I-Ad and HLA-DR1 by backbone-dependent and aromatic side chain-dependent interactions, respectively.Binding of gluten-derived peptides to the HLA-DQ2 (alpha1*0501, beta1*0201) molecule, assessed in a cellular assay.Processing and presentation of endocytically acquired protein antigens by MHC class II and class I molecules.Antigen presentation by MHC class II molecules.Membrane interactions influence the peptide binding behavior of DR1.pH dependence and exchange of high and low responder peptides binding to a class II MHC molecule.Evidence for a conformational change in a class II major histocompatibility complex molecule occurring in the same pH range where antigen binding is enhanced.Monoclonal antibodies specific for the empty conformation of HLA-DR1 reveal aspects of the conformational change associated with peptide binding.The antiphospholipid syndrome and SLE: is there a clue in the link between complement and coagulation?
P2860
Q21092228-14CA782C-CB94-4486-AA89-AC06F0C75F58Q26747063-9FE08E5B-EA0C-4927-A051-48C8A5833834Q28391460-E4B1DFAC-49C6-4895-BB10-034A6FB7A787Q28612958-A435527B-036F-40A1-8D29-B7F2F3C1B455Q33815435-C11F3623-94F2-4BFD-9253-C7C2022DB74DQ34540061-63B5347A-6A57-4D1E-BEFC-A1B9C3F7A4F6Q35107376-873B51FB-F6ED-4FDA-B215-579ED7B4A8BBQ36048493-FED348E9-4E93-428A-9C50-F195A0E76356Q36230148-9E84FB44-369F-47D1-A0F6-0CB9D6A4CA4CQ36230523-29E81500-3911-4100-BA51-A7D9C5503FFAQ36230570-FDADED86-E940-485E-BAB5-2E7C0121D1BEQ36230883-71809257-A274-4946-AD4D-996342FD3EF9Q36231727-1EC52891-3B86-4229-AA8E-1D30434A6E33Q36285397-1A6DE801-7C24-40A2-9CBE-4FC124E3E659Q36353782-DE430F4B-176C-415F-A6EC-7608E6FCAA8FQ36364817-BD3D18FA-C3E2-4876-807E-C0CB9A6FE0FBQ36366080-72F9005D-1D75-4666-A4FF-E9384EB3FD17Q36368876-119D3F85-3664-4630-9612-54EB978027ACQ36554333-7A9DD7AF-3BA1-4F81-904D-F483291E2A12Q36707417-78B228DC-2CFC-4A4E-8275-8DD3FF9B4A6EQ37460378-B18DB3E1-BB93-46B2-AC91-392897DDC0DDQ37519795-E593668D-7C0A-4680-AB96-345519841BA3Q37594729-8EFFA0AA-825D-4E8D-A9CD-ACCD50EA24CEQ38255165-A45196D9-F95B-45B9-BAAD-46C863DE8E80Q40826302-C63EB52B-64AF-45CD-BEF5-E12BD8F4CCE0Q40975287-D56A4A1B-F1AB-4B5A-85C8-0006361D9747Q41064237-2A4C48CB-C88E-475A-B4AA-4C56221E058DQ41168208-2B57D708-93AE-4CAB-A30B-88312D5A3D88Q41359341-4C0E8DAC-6573-4AE5-905B-6D962FDE0370Q41497170-FA60396F-9153-4F61-8CFD-55CA593C4A4FQ41530424-FF774E04-DF69-4D89-A599-B5B693612F14Q42279888-A9A77FD9-78C0-42D4-B6F4-EE28963DD5A6Q44752464-89F7E602-2805-42DD-ACEB-FDC6529E72BDQ57254750-E0B7BB7E-3827-4960-A7FB-D6CF87213E36
P2860
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年学术文章
@wuu
1990年学术文章
@zh-cn
1990年学术文章
@zh-hans
1990年学术文章
@zh-my
1990年学术文章
@zh-sg
1990年學術文章
@yue
1990年學術文章
@zh
1990年學術文章
@zh-hant
name
Regulation of antigen presentation by acidic pH.
@ast
Regulation of antigen presentation by acidic pH.
@en
type
label
Regulation of antigen presentation by acidic pH.
@ast
Regulation of antigen presentation by acidic pH.
@en
prefLabel
Regulation of antigen presentation by acidic pH.
@ast
Regulation of antigen presentation by acidic pH.
@en
P2860
P356
P1476
Regulation of antigen presentation by acidic pH.
@en
P2093
P E Jensen
P2860
P304
P356
10.1084/JEM.171.5.1779
P407
P577
1990-05-01T00:00:00Z